Sites Built To Deliver Enrollment

Lynd Clinical is a fully owned, purpose-built clinical research site network bringing trials directly to rural and community America.

What You Get With Lynd

    • Single, integrated eClinical platform across all sites (CTMS, eSource, eConsent, eReg)

    • Centralized study start-up, contracting, regulatory, patient recruitment, and quality—managed through a single operating model

    • Designed for consistent, audit-ready execution and high-integrity data

    • Feasibility turnaround: 24–48 hours

    • Contract execution: ~1 week

    • Site activation: 2–4 weeks

    • Direct access to underrepresented, community-based patient populations

    • Structured workflows from identification through enrollment

    • Built to improve conversion and reduce screen failures

    • Experienced investigators and site teams across key therapeutic areas

    • Purpose-built facilities and standardized infrastructure to support complex protocols

    • Integrated lab, imaging, and pharmacy capabilities

Lynd supports a broad and scalable portfolio of trials across high-demand therapeutic areas, including:

Metabolic/Endocrinology

Psychiatry

Neurology

Hepatology

Gastroenterology

Pulmonary/Respiratory

Cardiology

General Medicine

Purpose-Built Site Infrastructure

Each Lynd site is designed, built, and equipped to meet regulatory and protocol expectations from day one, supporting efficient start-up, high-quality execution, and sponsor readiness.

Standardized infrastructure across the network ensures consistent performance, faster activation, and a predictable experience for sponsors and CROs.

Site Capabilities:

  • Experienced PIs, sub-I’s, and research team

  • 3,500–4,000 sq. ft. dedicated research facilities

  • Fully equipped exam rooms and sponsor-ready monitoring space

  • Secure investigational product storage and handling

  • Dedicated unblinded pharmacy room with controlled access and preparation capabilities

  • Laminar flow hoods to support sterile and controlled study drug preparation

  • On-site lab and sample processing with central lab relationships and PBMC capabilities

  • Temperature-controlled storage, including 2–8°C refrigerators, −20°C freezers, and −80°C freezers

  • Room temperature and refrigerated centrifuges for on-site sample processing

  • Standardized advanced diagnostics at each site, including ultrasound and FibroScan

  • Established hospital and imaging partnerships for outpatient procedures

A Different Model

Lynd is purpose-built to address the limitations of traditional site networks—focused exclusively on rural and community-based markets.

  • Owned, not embedded – Lynd owns and operates its sites, maintaining full operational control

  • Integrated, not outsourced – Patient identification is embedded directly into site execution

  • Centralized, not fragmented – A single operating model drives consistency across all sites

Where We’re Launching

Initial sites are launching in Mississippi, Arkansas, and Alabama, with additional markets under development as Lynd expands into underserved and community-based regions.

Partner with Lynd Clinical

Bring your trial to patient populations other sites can’t reach - through a site network built for enrollment performance.